Glenn Whaley - 03 Jun 2025 Form 4 Insider Report for IMMUNIC, INC. (IMUX)

Reporting relationship: Chief Financial Officer
Issuer ticker: IMUX
Reported as of: 03 Jun 2025
Net transaction value: +$46,076
SEC form: 4
Accepted by SEC: 04 Jun 2025, 16:22:22 UTC
Prior SEC filing: 06 Dec 2024
Next SEC filing: 20 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Glenn Whaley

Key filing fact

Glenn Whaley filed Form 4 for IMMUNIC, INC. (IMUX) on 04 Jun 2025.

Key facts

This page summarizes Glenn Whaley's Form 4 filing for IMMUNIC, INC. (IMUX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 04 Jun 2025, 16:22.

Change

Previous filing in this sequence was filed on 06 Dec 2024.
Current net transaction value: +$46,076.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001724623 Primary reporting owner

Whaley Glenn

Relationship: Chief Financial Officer
Address: 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK
Signature: /s/ Glenn Whaley
Signature date: 04 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMUX transaction

Common Stock

Award

Transaction value: $14,000
Shares: +25,000
Change %: +98%
Price: $0.5600
Shares after: 50,510
Date: 30 May 2025
Ownership: Direct
Footnotes: F1, F2

IMUX transaction

Common Stock

Purchase

Transaction value: $32,076
Shares: +45,000
Change %: +89%
Price: $0.7128
Shares after: 95,510
Date: 03 Jun 2025
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Reporting Person (RP) is voluntarily reporting the acquisition of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c).

Footnote F2

In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 30, 2025.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7127 to $0.7134. The RP undertakes to provide to the Issuer, any securityholder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.